Oncologists have discovered that lung cancer cells can change their identity to resist treatment. Research published in ...

KRAS is one of the oncogenes most frequently altered in cancer, mutated in approximately one-third of lung adenocarcinomas.

Black Diamond's May 2026 silevertinib update showed steady NSCLC response rates, CNS activity and dose progress, but durability data remain early.

A single blood test could help doctors predict how lung cancer patients will respond to treatment before therapy begins, ...

Nuvalent (NUVL) has secured a U.S. review for its second product in less than a year after the FDA granted priority review for its marketing application targeting the lung cancer therapy neladalkib.

SAN ANTONIO, May 27, 2026--bioAffinity Technologies receives notice of allowance for Mexican patent on methods of predicting the likelihood of lung cancer using flow cytometry.

Cancer scientists have discovered that lung cancer cells can change their identity to resist treatment. Research published today [27 May] in Molecular Oncology reveals how lung cancer cells can become ...

Arima Genomics, Inc., a cancer diagnostics company bringing DNA sequence and structure together to advance cancer therapy selection, today announced that it will present new data at the 2026 American ...

Scientists, funded by Cancer Research UK, have now passed another hurdle, bringing the test closer to patient use ...

Partners Summit Therapeutics and Akeso are expected to steal the show at the American Society of Clinical Oncology’s annual ...

Oncology experts from all over the world will discuss the latest developments in care. The American Society of Clinical ...

GLP-1 drugs such as Ozempic, Wegovy, and Mounjaro have become widely known for helping people lose weight and control diabetes. Over the past few years, these medications have rapidly grown in ...